Get 20% lifetime commission for referring investors to digrin.com
here.
ImmunityBio, Inc. ( IBRX) - Key Metrics
IBRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.04 | -$0.06 | -$0.07 | -$0.07 |
| 2025Q3 | $0.03 | -$0.07 | -$0.07 | -$0.07 |
| 2025Q2 | $0.03 | -$0.10 | -$0.09 | -$0.09 |
| 2025Q1 | $0.02 | -$0.15 | -$0.10 | -$0.10 |
IBRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -7.91 |
| 2025Q3 | ? | -8.66 |
| 2025Q2 | ? | -6.33 |
| 2025Q1 | ? | -4.95 |
IBRX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.98% | ? |
| 2025Q4 | -3.64% | ? |
| 2025Q3 | -2.99% | ? |
| 2025Q2 | -3.45% | ? |
| 2025Q1 | -3.39% | ? |
IBRX
Price: $7.68
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.85 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.2 million
Market Capitalization: 9.3 billion